Ballast Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.37M Sell
108,775
-3,336
-3% -$97.4K 1.03% 48
2026
Q2
$4.06M Sell
112,111
-1,112
-1% -$38K 1.62% 32
2026
Q1
$3.74M Buy
113,223
+2,780
+3% +$118K 1.67% 31
2025
Q4
$5.11M Sell
110,443
-3,872
-3% -$162K 2.42% 15
2025
Q3
$4M Buy
114,315
+27,109
+31% +$942K 1.83% 26
2025
Q2
$2.58M Buy
+87,206
New +$2.49M 1.34% 32

Other funds holding COLL

Ballast Asset Management's COLL Position: Q3 2026 in Review

Ballast Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 3% in Q3 2026, selling an estimated $97.4K and leaving 108,775 shares worth $2.37M. The position accounts for 1.03% of the portfolio, ranked #48.

Ballast Asset Management first reported a position in COLL in Q2 2025 and has held it in 6 quarters since. The position peaked at $5.11M in Q4 2025. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Ballast Asset Management held 108,775 shares of Collegium Pharmaceutical worth $2.37M as of Q3 2026.
  • Ballast Asset Management sold 3,336 Collegium Pharmaceutical shares in Q3 2026, an estimated $97.4K.
  • Collegium Pharmaceutical made up 1.03% of Ballast Asset Management's portfolio in Q3 2026, its #48 holding.
  • Ballast Asset Management first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
  • Ballast Asset Management's Collegium Pharmaceutical position peaked at $5.11M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Ballast Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.